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Abstract
Purpose
In patients with massive or recurrent gastrointestinal bleeding (GIB) which is not amenable to
endoscopic therapy, angiographic interventions are often employed. We report our ten-year
experience of empiric transcatheter arterial embolization (TAE) for patients with massive or
recurrent GIB.
Methods
All patients who had undergone empiric TAE at our hospital between March 2004 and June 2015
were identified using the institutional radiology information system. A retrospective
chart review was performed using a structured pro forma. Technical success rate, 30-day
clinical success rate, 30-day mortality rate, and rate of procedural complications were
computed. Statistical analysis was performed using Statistical Package for Social Sciences
(SPSS) version 20.
Results
A total of 32 patients had undergone empiric TAE for GIB during the study period. The median
age of subjects was 56 years and two-thirds of them were male (68.7%). Gastroduodenal (n=24),
ileocolic (n=3), left gastric (n=2), right gastroepiploic (n=1), and branches of superior and
middle rectal arteries (n=1) were embolized using microcoils (n=25), polyvinyl alcohol particles
(n=25), and gelatin sponge (n=3)--either alone or in combination. Technical and 30-day clinical
success rates were 96.9% (31/32) and 71.9% (23/32), respectively. The 30-day mortality rate for
our cohort was 21.9% (7/32). One patient developed re-bleeding at two days after the initial
procedure and required repeat embolization. Coil migration (n=3) and access site hematoma
(n=1) were the observed procedural complications.
Conclusion
Empiric TAE can be a useful treatment option for selected patients with massive or recurrent
GIB that is not amenable to endoscopic therapy.
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Introduction
Gastrointestinal bleeding (GIB) accounts for more than 500,000 hospital admissions annually in
the United States with a cumulative healthcare cost of nearly five billion dollars [1]. Massive
GIB has been reported to have mortality rates as high as 24% and portends a worse prognosis
[2]. Endoscopic therapy is considered the first-line treatment for patients with massive
gastrointestinal hemorrhage [3-4]. However, this may not be possible in 8-25% of cases where
endoscopic therapy may be unsuccessful [5], or may not be technically feasible [6]. In such
cases, angiographic embolization or surgical ligation of bleeding vessels is the only available
treatment option [7].
Transcatheter arterial embolization (TAE) is a commonly performed procedure and an
estimated 1.7 million TAE procedures were performed in the United States in 2001 [8]. In
patients with massive GIB, digital subtraction angiography (DSA) of the celiac, superior
mesenteric and inferior mesenteric vessels can identify a source of bleeding in 30-47% of cases
[9]. Demonstration of active contrast extravasation or pseudo-aneurysm formation is a tell-tale
sign of active GIB and mandates TAE of the culprit vessel [10]. However, when DSA fails to
demonstrate any overt signs of bleeding, the decision to perform TAE of a specific vessel
becomes complicated. In many such cases, if the anatomic site of bleeding is known, 'empiric'
TAE of the relevant vascular territory is performed [11].
The technical feasibility and clinical success of TAE in patients with angiographic evidence of
active GIB has been well-established [12]. Moreover, the technical feasibility and clinical
success of empiric TAE has also been demonstrated, mainly in patients with GIB due to
duodenal ulcers [13-15]. However, in patients with massive or recurrent GIB due to other
etiologies, empiric TAE is employed less commonly. Data on the safety of empiric TAE in cases
of small intestinal or colonic bleeding is relatively scarce. In this retrospective study, we share
our ten-year experience of performing empiric TAE for patients with massive or recurrent GIB
due to a diverse array of etiologies.
Materials And Methods
A retrospective cross-sectional study was performed after obtaining an exemption from the
institutional ethics review committee. We used the institutional radiology system to identify
patients who had undergone empiric TAE for GIB at our institution between March 2004 and
June 2015. Medical records for all these patients were retrieved and systematically reviewed
using a structured pro forma. The data relating to demographics, co-morbidities, blood
transfusions, laboratory investigations, endoscopies, radiologic studies, etiology of GIB, details
of the TAE procedure, clinical outcome, and subsequent follow-up were specifically recorded.
Personal identifiers or other identifiable information was not recorded. We excluded those
patients who had less than 30 days of follow-up after the procedure. Etiology of GIB (if known)
was based upon a final consensus diagnosis as recorded by the primary physician in the hospital
chart.
Study site
Our hospital is a tertiary care center located in a densely populated city of a low-to-middle
income country. The hospital has a dedicated vascular and interventional radiology suite with
state-of-the-art facilities. This suite remains operational from 8 AM to 5 PM during which
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elective procedures are performed. Emergency procedures during daytime are performed
rapidly by temporarily suspending elective procedures. For the afterhours, a dedicated on-call
interventional radiology team consisting of technicians and a consultant interventional
radiologist is on standby. When consulted by treating physicians, the on-call team is mobilized
and the interventional radiology suite is activated for emergency procedures. Interventional
procedures are performed by three different consultant interventional radiologists, all of whom
have completed post-graduate training in radiology and dedicated fellowships in interventional
radiology. Also, all of them have more than five years of experience in performing
interventional radiologic procedures.
Protocol for management of GIB
Emergency physicians, gastroenterologists, and general surgeons consult the on-call vascular
and interventional radiology team for many patients with GIB. All patients undergoing TAE for
GIB at our institution have either massive or recurrent GIB where endoscopy and/or surgery
have failed, or are deemed unfeasible. In most patients with massive GIB, computed
tomography (CT) with GIB protocol is obtained prior to DSA in an attempt to localize the
source of bleeding. The decision to perform DSA is based on a consensus between the on-call
interventional radiologist and the primary treating physician. In patients who undergo DSA,
TAE is always attempted if angiographic evidence of active bleeding (active contrast
extravasation, pseudo-aneurysm formation, presence of arteriovenous fistulae or abnormal
vascular blush) is evident. In cases when angiographic findings of active bleeding are absent,
the decision to perform empiric TAE or not is taken by the performing interventional
radiologist. In most patients with recurrent GIB, the anatomic source of bleeding is evident
based on results of previous endoscopies, radiologic studies and/or operative findings, and
empiric TAE is attempted in such cases. However, in some patients with massive GIB, the
anatomic source of bleeding may not be known with certainty; in such cases, empiric TAE is not
performed if the interventional radiologist believes that the anatomic source of bleeding is not
known with certainty.
Interventional radiology procedures
For all patients included in the study, DSA procedures were performed in the interventional
radiology suite using a flat panel monoplane DSA machine (Angiostar®, Siemens Medical
Systems; Erlangen, Germany). The right or left groin was punctured to gain access to the
common femoral artery using a 4-Fr or 5-Fr vascular access sheath (Cordis; Miami, FL, USA).
Selective cannulation of the celiac, superior mesenteric and inferior mesenteric arteries was
then performed. Diagnostic angiographies were typically carried out using 4-Fr cobra (C1)
cordis, renal double curve (RDC), cordis or Simmons (SIM1) cordis catheters. TAE was
performed by a super-selective cannulation of suspected target vessels using a microcatheter
(Progreat, Terumo; Tokyo, Japan) followed by deployment of vascular occlusive microcoils (Balt
Extrusion; Montmorency, France), polyvinyl alcohol (PVA) particles (Boston scientific;
Marlborough, MA, USA), and/or gelatin sponges (Gelfoam, Pharmacia & Upjohn; Kalamazoo,
MI, USA). At our interventional radiology suite, N-butyl cyanoacrylate (NBCA) glue (Histoacryl,
B. Braun; Melsungen, Germany) is also available; however, it was not utilized by any consultant
interventional radiologist for performing empiric TAE among the subjects included in this
study. Following empiric TAE, repeat angiograms were performed to determine the adequacy of
TAE and to assess collateral vessels.
Operational definitions and statistical analysis
The technical success of TAE was defined as complete angiographic occlusion of the suspected
culprit vessel. The technical success rate was calculated as the ratio of the number of
technically successful empiric TAE procedures to the total number of procedures where a
decision to perform empiric TAE was made by the performing interventional radiologist.
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Clinical success was determined by a combination of technical success and no evidence of on-
going GIB (as suggested by clinical, laboratory and endoscopic findings) within the first 30 days
after the procedure. For the purpose of this study, the patients who died within the first 30 days
of the empiric TAE procedure were considered to have clinical failure. To calculate the 30-day
clinical success rate, we divided the number of patients with clinically successful empiric TAE
procedures to the total number of procedures where a decision to perform empiric TAE was
made. The 30-day mortality rate for our study cohort was computed as the ratio of the number
of patients alive at 30 days after the empiric TAE procedure to the total number of patients
included in this study. Statistical package for social sciences (SPSS) version 20.0 was used for
performing statistical analysis. Frequencies were calculated for qualitative variables, while
the median (inter-quartile range [IQR]) were computed for quantitative variables. We did not
use any statistical tests as no comparisons were performed in this descriptive study.
Results
A total of 32 subjects were included in this study with a predominance of men (n=22, 68.7%).
The median age of study subjects was 56 (IQR: 32-78) years. Duodenal ulcer (n=16, 50%) was
the most common etiology of GIB followed by malignancy (n=7, 21.9%), undetermined etiology
(n=4, 12.5%) and gastric ulcer (n=2, 6.2%). Most patients (n=29, 90.6%) had one or more
medical comorbidities with the most common being hypertension (n=25, 78.1%) and diabetes
mellitus (n=18, 56.2%). Laboratory evidence of abnormal hemostasis was evident in 11 (34.4%)
cases. The median nadir hemoglobin for our patients was 6.8g/dl (IQR: 5.2-7.1). Packed red
blood cells were transfused in all patients prior to TAE with a median number of 12 (IQR: 6-18)
units transfused per patient. These demographic characteristics are further summarized in
Table 1.
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Characteristics Results (n [%])
Sex
   Male 22 (68.7%)
   Female 10 (31.2%)
Age (median [IQR]) 56 (32–78) years
Etiology of gastrointestinal hemorrhage
   Duodenal ulcer 16 (50.0%)
   Malignancy 7 (21.9%)
   Undetermined 4 (12.5%)
   Gastric ulcer 2 (6.2%)
   Pancreatitis 1 (3.1%)
   Glanzmann thrombasthenia 1 (3.1%)
   Aorto-enteric fistula 1 (3.1%)
Medical co-morbidities
   Hypertension 25 (78.1%)
   Diabetes mellitus 18 (56.2%)
   Malignancy 10 (31.2%)
   Ischemic heart disease 7 (21.9%)
   Cerebrovascular disease 4 (12.5%)
   Liver cirrhosis 3 (9.4%)
   Others 3 (9.4%)
Nadir hemoglobin (median [IQR]) 6.8g/dl (5.2–7.1)
Number of packed RBC transfused (median [IQR]) 12 (IQR: 6–18) units per patient
TABLE 1: Characteristics of patients included in our study (n = 32)
IQR = interquartile range; RBC = red blood cell.
The anatomic sites of GIB were duodenum, stomach, cecum, and rectum in 25 (78.1%), 3 (9.4%),
3 (9.4%), and 1 (3.1%) cases, respectively. Empiric TAE was technically successful in 31/32
patients affording a technical success rate of 96.9%. In the particular case where TAE was
technically unsuccessful, the unusual anatomy of the gastroduodenal artery was noted on DSA.
The gastroduodenal artery was filling retrogradely from the superior mesenteric artery with
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subsequent retrograde filling of the hepatic and gastroepiploic arteries. Of the 31 patients that
had empiric TAE, seven patients died within the first 30 days giving a 30-day mortality rate of
21.9%. The most common causes of death included respiratory failure, myocardial
infarction, and septic shock. The cause of death was unrelated to the procedure in all cases.
One patient developed re-bleeding two days after undergoing TAE of the gastroduodenal artery.
This patient had Glanzmann thrombasthenia and, during the initial TAE procedure, a microcoil
had migrated inadvertently from gastroduodenal artery into the hepatic artery. Upon
performing repeat DSA, active contrast extravasation was noted from the gastroduodenal
artery, which was filling retrogradely through collateral vessels. Repeat embolization of the
culprit vessels was performed successfully with two microcoils. However, the patient developed
a groin hematoma from the repeat procedure. Subsequently, he had no evidence of GIB and
remained clinically stable afterwards. Re-bleeding was not noted in any other patient. The 30-
day clinical success rate was calculated to be 71.9% (23/32). The procedural complications that
occurred in our study participants were coil migration and groin hematoma, which occurred in
3 (9.4%) and 1 (3.1%) cases respectively. In all three cases of coil migration, patients had
extensive aorto-iliac atherosclerosis, which rendered the manipulation of angiographic
catheters extremely difficult. In all such cases, microcoils inadvertently migrated from the
gastroduodenal artery onto the right hepatic artery. However, in such cases, there was no
significant restriction of blood flow to the liver and none of these subjects had any clinical
evidence of abnormal hepatic function. The only patient who developed a groin hematoma had
a history of Glanzmann thrombasthenia and did well with conservative management.
Asymptomatic duodenal stenosis was discovered in three cases on post-TAE upper endoscopy,
which did not require any specific treatment. Other TAE-related complications, such as arterial
dissection, bowel infarction, acute renal failure or contrast reactions, were not observed in our
study cohort. The median duration of follow-up for our patients was 63 (IQR: 33-102) days.
Among patients who underwent TAE, the most commonly embolized vessels were the
gastroduodenal artery (n=24, 75%; Figure 1), the ileocolic artery (n=3, 9.4%; Figure 2), and the
left gastric artery (n=2, 6.2%; Figure 3) as given in Table 2. A combination of microcoils and
PVA particles (n=19, 59.4%) was used in most cases, followed by PVA particles alone (n=5,
15.6%) and microcoils alone (n=3, 9.4%). Microcoils and gelatin sponge were used in two (6.2%)
cases, while in one (3.1%) case, a combination of microcoils, PVA particles, and gelatin sponge
was utilized. NBCA glue was not used for empiric TAE in any case. Size of PVA particles used in
our study ranged from 355 μm to 500 μm.
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FIGURE 1: Empiric transcatheter arterial embolization of the
gastroduodenal artery
(a) Pre-embolization angiogram fails to reveal active contrast extravasation from the
gastroduodenal artery. (b) Post-embolization angiogram shows multiple microcoils (arrow) in the
gastroduodenal artery with no flow of contrast distally.
FIGURE 2: Empiric transcatheter arterial embolization of the
ileocolic artery
(a), (b) Pre-embolization angiograms fail to reveal any active contrast extravasation from the
ileocolic artery. (c) Post-embolization angiogram shows a microcoil (arrow) in the ileocolic artery
with significantly reduced vascularity.
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FIGURE 3: Empiric transcatheter arterial embolization of the
left gastric artery
(a) Pre-embolization selective left gastric angiogram shows no angiographic evidence of active
bleeding. (b) Post-embolization angiogram shows significantly reduced vascularity in the region of
gastric fundus (arrow) near the gastro-esophageal junction. Arterial embolization in this case was
performed with polyvinyl alcohol particles (355–500 μm).
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N Anatomicsites Etiologies
Technical
success Vessels embolized
Agents
employed
Clinical
outcome
24 Duodenum
Duodenal ulcer (n=16), malignancy
(n=6), Glanzmann thrombasthenia
(n=1), aorto-enteric fistula (n=1),
undetermined (n=1)
23/24 Gastroduodenalartery (n=23)
PVA particles
(n=19),
microcoils
(n=22), gelatin
sponge (n=2)
Success
(n=16), re-
bleeding
(n=1), died
(n=7)
3 Stomach Gastric ulcer (n=2), pancreatitis(n=1) 3/3
Left gastric artery
(n=2),
gastroduodenal and
right gastro-epiploic
arteries (n=1)
PVA particles
(n=3),
microcoils
(n=1)
Success
(n=3)
3 Cecum Undetermined (n=3) 3/3 Ileocolic artery (n=3)
PVA particles
(n=2),
microcoils
(n=1)
Success
(n=3)
1 Rectum Malignancy (n=1) 1/1
Branches of
superior and middle
rectal arteries (n=1)
Microcoils +
PVA particles +
gelatin sponge
(n=1)
Success
(n=1)
TABLE 2: Results of transcatheter arterial embolization performed in study subjects
(n = 32)
PVA = polyvinyl alcohol.
Discussion
Our study demonstrates that empiric TAE is a technically feasible procedure in patients with a
known anatomic site of GIB where endoscopic or surgical therapy has failed, or is deemed
unfeasible. The clinical success rate (71.7%) that we reported in our study is comparable to that
reported by previous studies [5,7,10-15]. Aina et al. reported a clinical success rate of 76% in a
cohort of 75 patients who underwent TAE for upper GIB [11]. Likewise, Ichiro and co-workers
found that empiric TAE for bleeding duodenal ulcers had a clinical success rate of 83% [14].
Furthermore, in another study, Dixon and colleagues showed that the clinical success rate for
empiric TAE (80%) in patients with upper GIB was comparable to that for TAE (85%) performed
in patients with angiographic evidence of upper GIB [16].
In patients with recurrent or massive GIB, angiographic findings of hemorrhage (active contrast
extravasation, pseudo-aneurysm formation or arterial spasm) may not always be evident [2]. In
cases where angiographic evidence of GIB is absent, 'empiric' or 'blind' TAE may be performed
in the anatomic site of GIB [7]. Although such a procedure is termed 'empiric' or 'blind', the
anatomic site of GIB is usually certain based on radiologic, endoscopic, and/or operative
findings [5]. Such a technique of performing TAE in the absence of angiographic evidence of
active bleeding is also employed for various other purposes in different case scenarios. For
instance, TAE is often employed pre-operatively for highly vascular tumors to reduce their
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vascularity and ameliorate the severity of intra-operative bleeding [17].
The absence of angiographic evidence of bleeding does not preclude recent, or even active, GIB.
In many patients, GIB is intermittent and may not be evident at the time of DSA [18]. Moreover,
in patients with active GIB, systemic hypotension can mask frank contrast extravasation at the
site of bleeding. Animal-based models of conventional angiography suggest that catheter-based
DSA cannot detect bleeding if it occurs at a rate of less than 0.5 mL per minute [19].
Additionally, vessels may go into vasospasm and this may be another reason for the absence of
angiographic contrast extravasation [20]. Due to the aforementioned reasons, empiric TAE can
establish hemostasis and effectively control hemorrhage in patients with massive or recurrent
GIB provided the anatomic site of bleeding is certain and the target vessels are embolized
completely [11].
The 30-day clinical success rate in our study was comparable to other studies [5,7,10-15].
However, there is considerable discrepancy amongst published studies regarding the definition
of “clinical success rate” [13]. In our study, we excluded patients who died from any cause and
considered them as failures for the purpose of this calculation. The reason for doing this was to
increase the power of the study as attributing death to GIB or the procedure is extremely
subjective. For instance, myocardial infarction, respiratory failure and/or septic shock can
frequently occur as sequelae of prolonged, uncontrolled hemorrhage. Given the subjectivity
and bias inherent in such a determination, we decided to deem all patients, who died of any
cause within the first 30 days after empiric TAE, as clinical failures. However, not all
investigators concur with this method of calculating clinical success rate [10-15].
Efficacy of different embolic agents used for TAE could not be assessed in this small
retrospective study. However, NBCA glue was not used in any case by our interventional
radiologists. Traditionally, NBCA glue has been avoided for performing TAE in patients with
GIB due to fear of spillage of NBCA glue into nearby vessels [7]. However, in a recent
systematic review, Kim and colleagues analyzed 440 cases from 15 different studies and
reported that NBCA glue is a safe and effective agent for embolization of vessels in patients
with GIB [21]. In the present study, under-utilization of NBCA glue was most likely a combined
consequence of radiologists’ personal preferences and a lack of experience in using NBCA glue
for such cases.
The most common complication of TAE is re-bleeding, which has been previously reported to
occur in approximately 11-24% of cases [11,14,16]. The rate of re-bleeding observed in our
study was much lower than that reported in the literature. This may be attributable to
meticulous procedural technique and experience of individual radiologists in performing TAE
and employing the use of multiple embolic agents to secure hemostasis. However, a substantial
proportion of patients in our study cohort died within the first 30 days (21.9%), which may have
led to an underestimation of re-bleeding events. Having said that, the 30-day mortality rate of
our study cohort (21.9%) is in line with observations of previous studies; the mortality of
massive GIB is estimated to be as high as 24% [2]. In the only patient who developed re-
bleeding in our study, TAE procedure was complicated by coil migration and re-bleeding
occurred two days after the procedure. This observation is consistent with published literature
which suggests that early re-bleeding after TAE is most likely a consequence of poor technique
[11]. From a theoretical perspective, culprit vessels go into vasospasm at the time of TAE, which
would provide a false impression of hemostasis. Later, when such vessels dilate and re-open,
they provide a source of collateral flow and result in re-bleeding [22]. Based on this premise,
the use of provocative angiography has been explored by some researchers [23], although its
feasibility and safety remains to be established. Provocative angiography is not employed at
our institution due to safety concerns that fibrinolytics can potentially worsen GIB and
vasodilators may precipitate lethal hypotension in critically ill patients with massive GIB [14].
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A number of other complications have been reported in patients undergoing TAE for GIB [7].
Arterial dissection, bowel infarction, and anaphylaxis are rare complications, which were not
observed in our study cohort. Access site-related complications, such as hematoma and
pseudo-aneurysm formation, have been reported to occur in a small subset of patients [11]. In
our study, only one patient developed groin hematoma and did well with conservative
management; this patient had a history of Glanzmann thrombasthenia. Hepatic infarction and
fulminant hepatic failure have been reported to occur in some patients undergoing TAE for GIB
[7,11]. In our study, inadvertent coil migration occurred in three cases and, in all these cases,
microcoils migrated from the gastroduodenal artery into the hepatic artery. However, evidence
of hepatic failure or dysfunction was not observed in any case. Duodenal ischemia is a known
complication of TAE of the gastroduodenal artery and may be detected in later stages as
duodenal stenosis [7,11,15]. In our study, symptomatic duodenal ischemia did not occur in any
patient, but, asymptomatic duodenal stenosis was later detected in only three cases. Moreover,
among patients who underwent ileocolic artery and rectal artery TAE, intestinal infarction or
ischemic procto-colitis did not occur in any patient.
Ileocolic artery TAE is a less commonly performed procedure and limited literature is available
to support its technical feasibility and safety [10,24]. In the three patients who underwent this
procedure in our study, the anatomic site of bleeding was confirmed by CT with GIB protocol.
As mentioned previously, CT with GIB protocol is performed for most patients with massive
GIB at our institution prior to diagnostic angiography. In a previous study published in 2016,
we showed that CT with GIB is superior to RBC scintigraphy in terms of detecting GIB and
localizing an anatomic site [25]. Some investigators do not favor this approach due to the fear of
increasing the incidence of acute kidney injury and losing precious time in performing the CT
scan [14]. However, modern multi-row CT scanners with automated bolus tracking techniques
can perform such scans within a span of five minutes. Furthermore, in a study published in
2015, Jacovides and co-workers showed that use of such a diagnostic algorithm improves
localization and yield of diagnostic angiography without increasing the incidence of acute
kidney injury among such subjects [26].
This study does come with a number of caveats. First of all, our study was a retrospective charts
review and improper documentation might have led to an underestimation of certain
complications. However, our hospital is accredited by the Joint Commission International and
special emphasis is placed on proper documentation and accurate charting. Secondly, we only
reviewed the charts of patients who underwent empiric TAE for GIB in this study and did not
have a control group. But, the results observed in our study were comparable to those reported
by previous studies, which suggests that TAE is a feasible procedure. Additionally, our study
had a small sample size, which precluded the determination of predictors of re-bleeding or
mortality. Lastly, our study was from a single tertiary care center in a developing country;
therefore, the rate of complications observed in our study may not be generalizable to centers
of other lower-income countries where experienced radiologists may not always be available.
Despite these limitations, our study did provide some evidence in support of the feasibility and
safety of empiric TAE as a therapeutic option for patients with GIB.
Conclusions
Empiric TAE is a technically feasible and safe therapeutic option for patients with recurrent or
massive GIB from a known anatomic source where endoscopic therapy has failed, or is deemed
unfeasible.
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